Log in

GlaxoSmithKline Price Target, Predictions & Analyst Ratings

GBX 1,487.60
-38.00 (-2.49 %)
(As of 09/21/2020 12:00 AM ET)
Today's Range
Now: GBX 1,487.60
50-Day Range
MA: GBX 1,521.46
52-Week Range
Now: GBX 1,487.60
Volume5.70 million shs
Average Volume8.67 million shs
Market Capitalization£74.64 billion
P/E Ratio11.21
Dividend Yield5.01%

Analyst Ratings

GlaxoSmithKline (LON:GSK) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
17 Wall Street analysts have issued ratings and price targets for GlaxoSmithKline in the last 12 months. Their average twelve-month price target is GBX 1,830.20The high price target for GSK is GBX 2,240 and the low price target for GSK is GBX 1,550. There are currently 3 sell ratings, 8 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
GSK Consensus Rating: HoldHoldHoldHold
GSK Consensus Rating Score:
GSK Analyst Ratings: 3 Sell Rating(s)
8 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
10 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
10 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
8 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
GSK Consensus Price Target: GBX 1,830.20GBX 1,825.18GBX 1,849.88GBX 1,839.20

GlaxoSmithKline (LON:GSK) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

GlaxoSmithKline (LON:GSK) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
9/22/2020JPMorgan Chase & Co.Set Price TargetNeutralGBX 1,650
9/1/2020Morgan StanleyLower Price TargetUnderweightGBX 1,725 ➝ GBX 1,700
8/12/2020UBS GroupReiterated RatingBuyGBX 1,800
7/31/2020Goldman Sachs GroupLower Price TargetBuyGBX 2,060 ➝ GBX 2,020
7/31/2020DZ BankLower Price TargetBuyGBX 1,900 ➝ GBX 1,850
7/30/2020Credit Suisse GroupLower Price TargetNeutralGBX 1,860 ➝ GBX 1,700
7/29/2020BarclaysReiterated RatingUnderweight
7/20/2020Shore CapitalReiterated RatingSell
7/15/2020CitigroupReiterated RatingNeutral
6/29/2020Jefferies Financial GroupReiterated RatingBuy
6/22/2020Oddo BhfReiterated RatingNeutralGBX 1,840
6/22/2020Oddo SecuritiesBoost Price TargetNeutralGBX 1,760 ➝ GBX 1,840
5/28/2020Liberum CapitalReiterated RatingHold
4/6/2020Deutsche BankReiterated RatingHoldGBX 1,600
2/13/2020Societe GeneraleLower Price TargetBuyGBX 2,300 ➝ GBX 2,240
2/12/2020HSBCLower Price TargetBuyGBX 2,110 ➝ GBX 2,050
2/6/2020Bryan, Garnier & CoLower Price TargetNeutralGBX 1,800 ➝ GBX 1,773
9/13/2019Bank of AmericaSet Price TargetNeutralGBX 1,900
8/27/2019Kepler Capital MarketsSet Price TargetNeutralGBX 1,600
12/4/2018CfraSet Price TargetNeutralGBX 1,620
9/11/2018BNP ParibasSet Price TargetBuyGBX 1,750
8/23/2018Berenberg BankReiterated RatingBuyGBX 1,790
2/8/2018Beaufort SecuritiesUpgradeBuyGBX 1,450 ➝ GBX 1,500
2/7/2018Sanford C. BernsteinSet Price TargetNeutralGBX 1,580
11/6/2017InvestecDowngradeHoldGBX 1,800 ➝ GBX 1,390
10/26/2017S&P GlobalSet Price TargetNeutralGBX 1,500
(Data available from 9/22/2018 forward)
This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.